Literature DB >> 28656250

MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.

Lan Chen1, Yaxuan Cao1, Dongyun Rong1, Ye Wang1, Yu Cao1.   

Abstract

MicroRNAs (miRNAs) play crucial roles in the initiation and progression of various cancers, including melanoma. Recently, the genetic variants and deregulation of miR-605 have been reported to participate in carcinogenesis. However, the expression status of the miR-605 in melanoma tissues and its role in melanoma progression remain unknown. In this study, we found that miR-605 was significantly downregulated in melanoma cell lines and clinical specimens. Further function studies demonstrated that miR-605 suppressed melanoma cell growth both in vitro and in vivo. Moreover, INPP4B gene was identified as a target of miR-605 through bioinformatics analysis and luciferase reporter assays. Further analysis demonstrated that the inhibition of INPP4B mediated SGK3 activation was required for the suppressive role of miR-605 on melanomas cell growth. Collectively, our data suggest that miR-605 functions as a tumor suppressor by negatively regulating INPP4B mediated SGK3 activation in melanoma and may present a potential target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28656250     DOI: 10.3892/or.2017.5740

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  MicroRNA-3666 Suppresses Cell Growth in Head and Neck Squamous Cell Carcinoma Through Inhibition of PFKFB3-Mediated Warburg Effect.

Authors:  Lan Chen; Yaxuan Cao; Bei Wu; Yu Cao
Journal:  Onco Targets Ther       Date:  2020-09-10       Impact factor: 4.147

Review 2.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  microRNA-605 inhibits the oncogenicity of non-small-cell lung cancer by directly targeting Forkhead Box P1.

Authors:  Wei Zhou; Ruichao Li
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

4.  INPP4B promotes colorectal cancer cell proliferation by activating mTORC1 signaling and cap-dependent translation.

Authors:  Xin-Hua Ruan; Xi-Mei Liu; Zhi-Xiang Yang; Shao-Peng Zhang; Quan-Zheng Li; Chun-Sheng Lin
Journal:  Onco Targets Ther       Date:  2019-04-23       Impact factor: 4.147

5.  microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.

Authors:  Jianwu Jia; Jing Wang; Meifeng Yin; Yongdong Liu
Journal:  Onco Targets Ther       Date:  2019-07-08       Impact factor: 4.147

6.  Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.

Authors:  Emily Marie Mangialardi; Keyue Chen; Brittany Salmon; Jean Vacher; Leonardo Salmena
Journal:  Oncotarget       Date:  2019-10-29

Review 7.  The miRNAs Role in Melanoma and in Its Resistance to Therapy.

Authors:  Francesca Varrone; Emilia Caputo
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 8.  Export Control: Post-transcriptional Regulation of the COPII Trafficking Pathway.

Authors:  Brittany J Bisnett; Brett M Condon; Caitlin H Lamb; George R Georgiou; Michael Boyce
Journal:  Front Cell Dev Biol       Date:  2021-01-12

9.  MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.

Authors:  Paul M McKeever; Raphael Schneider; Foad Taghdiri; Anna Weichert; Namita Multani; Robert A Brown; Adam L Boxer; Anna Karydas; Bruce Miller; Janice Robertson; Maria Carmela Tartaglia
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

10.  LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis.

Authors:  Cheng Ju; Ruihao Zhou; Jun Sun; Feifei Zhang; Xiaofeng Tang; Kaddie Kwok Chen; Junliang Zhao; Xiaoyong Lan; Shifan Lin; Zhiping Zhang; Xiao-Bin Lv
Journal:  Cancer Cell Int       Date:  2018-09-18       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.